A randomized trial of telemedicine efficacy and safety for nonacute headaches
Source: Müller et al. 2017 - Pubmed ID: 28615434
Setting: Norway, Single center and University Hospital
Study design:
RCT
Follow-up: 12 months
Patient group:
Sample size:
Total: 409(291)
IG: 205(151)
CG: 204(140)
Inclusion criteria:
- Referral to neurologist for non-acute headache diagnostic clarification and/or treatment
- Lack of abnormal findings on neurological examination and/or imaging
Type of technology:
Videoconsultation
- Diagnosis or treatment of non-acute headaches
Intervention:
Intervention: Comparing telemedicine to normal consultations for diagnosing and treating non-acute headaches – 12 month follow-up
Duration: 1 consultation, 12 month follow-up
Add on: –
Control group: Usual Care
Clinical effect:
- Headache Impact Test-6 →
- Visual Analogue Scale →
- Headache days/month →
- Painkillers and triptan use →
- Unchanged working status↑ (better in control group)
Patient safety:
- Secondary headaches →
- Requisitioned brain imaging results →
- Hospitalizations →
- Compliance →
Patient experiences/
Staff experiences:
Patient experiences: NA
Staff experiences: NA
Investment:
Equipment/Materials
- Videoconsultations
Running: NA
Organization: NA
Health care utilization:
- Hospitalizations →